Compare SCWO & POM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | SCWO | POM |
|---|---|---|
| Founded | 2021 | 2015 |
| Country | United States | China |
| Employees | N/A | N/A |
| Industry | Environmental Services | Other Specialty Stores |
| Sector | Utilities | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 45.2M | 47.2M |
| IPO Year | 2022 | N/A |
| Metric | SCWO | POM |
|---|---|---|
| Price | $2.87 | $0.24 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 55.9K | ★ 1.2M |
| Earning Date | 05-14-2026 | 05-03-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $215,037.00 | N/A |
| Revenue This Year | $5,945.19 | N/A |
| Revenue Next Year | $106.82 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.16 | $0.19 |
| 52 Week High | $3.60 | $6.43 |
| Indicator | SCWO | POM |
|---|---|---|
| Relative Strength Index (RSI) | 51.88 | 38.44 |
| Support Level | $2.35 | $0.20 |
| Resistance Level | $2.97 | $0.27 |
| Average True Range (ATR) | 0.32 | 0.04 |
| MACD | -0.01 | -0.01 |
| Stochastic Oscillator | 37.17 | 7.23 |
374Water Inc offers a technology that transforms wet wastes such as sewage sludge, biosolids, food waste, hazardous and non-hazardous waste, and forever chemicals (e.g., PFAS) into recoverable resources by focusing on waste as a valuable resource for water, energy, and minerals. The company's business activities include manufacturing processes and waste recycling and treatment processes, which currently involve the use, treatment, storage, transfer, handling and/or disposal of hazardous materials, chemicals and wastes.
Pomdoctor Ltd is an online medical services platform for chronic diseases in China. With a focus on chronic disease management and pharmaceutical services, its business model forms a one-stop platform for medical services, which organically connects patients to doctors and pharmaceutical products. Its experience in tackling chronic diseases can be traced back to the launch of its platform on mobile devices. The company operates in two segments: Internet hospital, and Pharmaceutical supply chain. The majority of revenue is derived from the Pharmaceutical supply chain segment.